We aimed at evaluation of the clinicoepidemiologic data of patients with gastric carcinoma in the Egyptian Delta as regards the etiologic factors, behavior, presenting symptoms, and tumor location, grade, and stage with highlighting of the treatment modalities, survival, and prognostic factors. Three hundred cases with gastric carcinoma were enrolled, diagnosed, and treated in a tertiary oncology center in the Egyptian Delta. Data were collected as regards the etiology, presenting symptoms, family history, comorbid conditions, treatment modalities, responses, recurrences, and survival outcomes. Univariate and multivariate analyses were done to correlate the different clinicopathologic factors with the overall and disease-free survivals. Male to female ratio was 2:1. The median age was 43 years. The main tumor location was in the gastric body. Pain was the commonest presenting symptom (36%). Most of the cases were stage IV (42.0%). Only 49% of cases were operable. On multivariate analysis, age more than 60 years, performance status 3–4, high grade, diffuse type, T4 lesions, N2 and N3, and the presence of metastasis were independently associated with worse OS. We report a clinic-epidemiologic study of gastric carcinoma in the Egyptian delta; the age at presentation was a decade earlier than that recorded in the USA and Europe; most of the cases were sporadic, located mostly at the body. Most of the cases were presented at stage IV with poor response to neoadjuvant therapy with a poorer overall survival than that recorded in the USA and Europe.
Epidemiology Gastric Cancer Surgery
This is a preview of subscription content, log in to check access.
Compliance with Ethical Standards
This work was carried out in the period from January 2010 until June 2016 according to the guidelines of the Declaration of Helsinki and it was approved by the local institutional ethical committee review board (Code: R/17.07.51).
Conflict of Interest
The authors declare that they have no conflict of interest.
McGuire S (2016) World Cancer report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Adv Nutr 7(2):418–419CrossRefGoogle Scholar
La Vecchia C, Negri E, Franceschi S, Gentile A (1992) Family history and the risk of stomach and colorectal cancer. Cancer 70(1):50–55CrossRefGoogle Scholar
Hirohata T, Kono S. Diet/nutrition and stomach cancer in Japan.Int J Cancer. 1997;Suppl 10:34–36CrossRefGoogle Scholar
Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007;10(2):75–83CrossRefGoogle Scholar
Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008;19(7):689–701CrossRefGoogle Scholar
Wong BC, Lam SK, Wong WM et al (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. J Am Med Assoc 291(2):187–194CrossRefGoogle Scholar
Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis: pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol . 2013;10(9):529–541CrossRefGoogle Scholar
Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, al Humaidi AH, Parikh AA (2016) An update on gastric cancer. Curr Probl Surg 53:449–490CrossRefGoogle Scholar
Wanebo HJ, Kennedy BJ, Chmiel J, Steele Jr G, Winchester D, Osteen R (1993) Cancer of the stomach. Ann Surg 218(5):583–592CrossRefGoogle Scholar
Postlewait LM, Maithel SK (2016) The importance of surgical margins in gastric cancer. J Surg Oncol 113(3):277–282CrossRefGoogle Scholar
Akagi T, Shiraishi N, Kitano S (2011) Lymph node metastasis of gastric cancer. Cancers (Basel) 3(2):2141–2159CrossRefGoogle Scholar
Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20CrossRefGoogle Scholar
Kelley JR, Duggan JM (2003) Gastric cancer epidemiology and risk factors. COMMENTARY. J Clin Epidemiol 56:1–9CrossRefGoogle Scholar
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefGoogle Scholar
Khalifa MM, Sharaf RR, Aziz RK (2010) Helicobacter pylori: a poor man’s gut pathogen? Gut Pathogens 2:2CrossRefGoogle Scholar
Eslick GD, Lim LL, Byles JE et al (1999) Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 94(9):2373–2379CrossRefGoogle Scholar
Xue F-B, Xu Y-Y, Wan Y, Pan B-R, Ren J, Fan D-M (2001) Association of H. Pylori infection with gastric carcinoma: a meta-analysis. World J Gastroenterol 7(6):801–804CrossRefGoogle Scholar
IARC. Schistosomes, liver flukes and helicobacter pylori. IARC monographs of the evaluation of carcinogenic risks to humans 1994;61:177–241Google Scholar
Tobacco smoke and involuntary smoking. Lyon, France: World Health Organisation ; 2004Google Scholar
Sjodahl K, Lu Y, Nilsen TI et al (2007) Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study. Int J Cancer 120:128–132CrossRefGoogle Scholar
Barber M, Fitzgerald RC, Caldas C (2006) Familial gastric cancer—aetiology and pathogenesis. Best Pract Res Clin Gastroenterol 20:721–734CrossRefGoogle Scholar
Edge SB, Compton CC (2010) The American joint committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474CrossRefGoogle Scholar
Akoh JA, Macintyre IM (1992) Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg 79:293–299CrossRefGoogle Scholar